Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia

Daniel C. Javitt, Robert W. Buchanan, Richard S.E. Keefe, Robert Kern, Robert P. McMahon, Michael F. Green, Jeffrey Lieberman, Donald C. Goff, John G. Csernansky, Joseph Patrick McEvoy, Fred Jarskog, Larry J. Seidman, James M. Gold, David Kimhy, Karen S. Nolan, Deanna S. Barch, M. Patricia Ball, James Robinson, Stephen R. Marder

Research output: Contribution to journalArticlepeer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences